The agency appears likely to authorize a third Pfizer dose for older Americans and those vulnerable to severe COVID-19. It’s preparing to address other big questions in coming weeks, including vaccines for children under 12.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
